Title: Maxson JE, et al. Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.
1234480-50-2
2108526-77-6
1225380-87-9 | tert-Butyl 4-(2,2-difluoroethyl)piperazine-1-carboxylate | AA00A13Q | MFCD20441471
141774-20-1 | (S)-2,6-Diamino-N-[(1-(1-oxotridecyl)-2-piperidinyl)methyl]hexanamide hydrate dihydrochloride | AA00A1DM | MFCD27977564
1221792-28-4 | 2-(3-[2-Amino-5-(trifluoromethyl)-3-pyridinyl]-2-propynyl)-1h-isoindole-1,3(2h)-dione | AA00A2OK | MFCD14584841
1388057-23-5 | 5-BroMo-6-chloro-1,3-dihydro-benzoiMidazol-2-one | AA00A5KX | MFCD22561319
141946-05-6 | 1-THIEN-2-YL-1,4-DIHYDRO-5H-TETRAZOL-5-ONE | AA00A9LC | MFCD07345592
1354951-08-8 | 2-(TETRAHYDROFURAN-3-YL)MALONICACID | AA00AAPD | MFCD18800838
169397-99-3 | 1,8-OCTANEDIOIC-D12 ACID | AA00AB13 | MFCD00068293
176504-01-1 | Fmoc-4-aminomethyl-phenylacetic acid | AA00AB8V | MFCD01321022
187227-45-8 | Oseltamivir acid | AA00ABIC | MFCD00953940
1616113-45-1 | Antibiotic-202 | AA00ABO7 | MFCD28144726